Cargando…

ANMCO position paper on vericiguat use in heart failure: from evidence to place in therapy

In the growing therapeutic armamentarium for heart failure (HF) management, vericiguat represents an innovative therapeutic option. The biological target of this drug is different from that of other drugs for HF. Indeed, vericiguat does not inhibit neuro-hormonal systems overactivated in HF or sodiu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Fusco, Stefania Angela, Alonzo, Alessandro, Aimo, Alberto, Matteucci, Andrea, Intravaia, Rita Cristina Myriam, Aquilani, Stefano, Cipriani, Manlio, De Luca, Leonardo, Navazio, Alessandro, Valente, Serafina, Gulizia, Michele Massimo, Gabrielli, Domenico, Oliva, Fabrizio, Colivicchi, Furio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194817/ https://www.ncbi.nlm.nih.gov/pubmed/37213802 http://dx.doi.org/10.1093/eurheartjsupp/suad106

Ejemplares similares

ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndrome
por: De Luca, Leonardo, et al.
Publicado: (2023)

ANMCO position paper ‘Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation’
por: Mocini, David, et al.
Publicado: (2022)

ANMCO POSITION PAPER: Use of sacubitril/valsartan in hospitalized patients with acute heart failure
por: Di Tano, Giuseppe, et al.
Publicado: (2021)

ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes
por: De Luca, Leonardo, et al.
Publicado: (2022)

ANMCO position paper: 2022 focused update of appropriate use criteria for multimodality imaging: aortic valve disease
por: Nardi, Federico, et al.
Publicado: (2022)

ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosis
por: Casolo, Giancarlo, et al.
Publicado: (2021)

ANMCO POSITION PAPER: The reorganization of cardiology in times of the SARS-CoV-2 pandemic
por: Caldarola, Pasquale, et al.
Publicado: (2021)

ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation
por: Di Fusco, Stefania Angela, et al.
Publicado: (2022)

ANMCO POSITION PAPER: Timing of coronary angiography in non-ST-segment elevation acute coronary syndromes
por: Murrone, Adriano, et al.
Publicado: (2021)

ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)
por: Bisceglia, Irma, et al.
Publicado: (2021)

ANMCO POSITION PAPER: Role of intra-aortic balloon pump in patients with acute advanced heart failure and cardiogenic shock
por: Rossini, Roberta, et al.
Publicado: (2021)

Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)
por: Mocini, David, et al.
Publicado: (2021)

ANMCO Position Paper: diagnostic–therapeutic pathway in patients with hypercholesterolaemia and statin intolerance
por: Gulizia, Michele Massimo, et al.
Publicado: (2017)

Spotlight on Italian Association of Hospital Cardiologists (ANMCO) activity in the 2–year period 2021–2023
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

ANMCO-SIMEU consensus document: appropriate management of atrial fibrillation in the emergency department
por: Caldarola, Pasquale, et al.
Publicado: (2023)

ANMCO Position Paper: hospital discharge planning: recommendations and standards
por: Mennuni, Mauro, et al.
Publicado: (2017)

ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives
por: Nardi, Federico, et al.
Publicado: (2017)

ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes
por: Colivicchi, Furio, et al.
Publicado: (2017)

ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death
por: Casolo, Giancarlo, et al.
Publicado: (2023)

Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey
por: Canale, Maria Laura, et al.
Publicado: (2021)

ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy
por: Riccio, Carmine, et al.
Publicado: (2017)

Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey
por: Canale, Maria Laura, et al.
Publicado: (2022)

Italian Association of Hospital Cardiologists practical guidance for sodium–glucose cotransporter 2 inhibitors use in patients with heart failure
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
por: Aimo, Alberto, et al.
Publicado: (2021)

ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes
por: Gronda, Edoardo, et al.
Publicado: (2021)

“My ANMCO Congresses”
por: Gabrielli, Domenico
Publicado: (2019)

ANMCO/SIC Consensus Document: cardiology networks for outpatient heart failure care
por: Aspromonte, Nadia, et al.
Publicado: (2017)

ANMCO-SIMEU Consensus Document: in-hospital management of patients presenting with chest pain
por: Zuin, Guerrino, et al.
Publicado: (2017)

ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure
por: Aspromonte, Nadia, et al.
Publicado: (2017)

The Impact of the Coronavirus Disease-2019 Pandemic and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure
por: Colivicchi, Furio, et al.
Publicado: (2020)

COVID-19, Vaccines, and Thrombotic Events: A Narrative Review
por: Abrignani, Maurizio G., et al.
Publicado: (2022)

ANMCO/SIT Consensus Document: telemedicine for cardiovascular emergency networks
por: Caldarola, Pasquale, et al.
Publicado: (2017)

Clinical pathways and management of antithrombotic therapy in patients with acute coronary syndrome (ACS): a Consensus Document from the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Society of Emergency Medicine (SIMEU) and Italian Society of Interventional Cardiology (SICI-GISE)
por: De Luca, Leonardo, et al.
Publicado: (2017)

Impact of Working from Home on Cardiovascular Health: An Emerging Issue with the COVID-19 Pandemic
por: Di Fusco, Stefania Angela, et al.
Publicado: (2021)

Vericiguat for Heart Failure with Reduced Ejection Fraction
por: Lombardi, Carlo Mario, et al.
Publicado: (2021)

ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism
por: D’Agostino, Carlo, et al.
Publicado: (2017)

BLITZ‐HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines
por: Gulizia, Michele Massimo, et al.
Publicado: (2022)

Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures
por: Caporale, Roberto, et al.
Publicado: (2017)

Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease
por: Gulizia, Michele Massimo, et al.
Publicado: (2018)

ANMCO/AIOM/AICO Consensus Document on clinical and management pathways of cardio-oncology: executive summary
por: Tarantini, Luigi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jvsctkst7fl6c143a82ves0qoh